COMMUNIQUÉS West-GlobeNewswire

Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting
25/06/2018
Two Nuclear Medicine focused advisory boards have been formed to provide expertise and strategic guidance to Actinium Meeting with Iomab-B and Actimab investigators to be held to provide trial updates and discuss [...]
Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has entered into a Common Shares Purchase Agreement (the “Agreement”) of up to $15.5 [...]
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
25/06/2018
DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category [...]
Opiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
25/06/2018
Initial $500,000 to be Utilized to Advance the Development of OPNT003 SANTA MONICA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company [...]
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
25/06/2018
Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO) (the “Company”), a leading provider of cancer-focused genetic testing services [...]
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Biogen to Report Second Quarter 2018 Financial Results on July 24, 2018
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Biogen Inc . (Nasdaq:BIIB) today announced it will report second quarter 2018 financial results on Tuesday, July 24, 2018, before the financial markets open. Following [...]
The Alliance for Regenerative Medicine Submits Comments to CMS Regarding Medicare's Hospital Inpatient Prospective Payment Systems New Technology Add-on Payment Program
25/06/2018
WASHINGTON, D.C., , June 25, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector [...]
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX® (cannabidiol) oral solution – the First Plant-derived Cannabinoid Prescription Medicine
25/06/2018
Approval for seizures associated with Lennox-Gastaut Syndrome or Dravet Syndrome, two rare, severe childhood-onset epilepsies LONDON and CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq [...]
CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions
25/06/2018
MENLO PARK, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today [...]
Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®
25/06/2018
In a Post-Hoc Analysis of Elderly Diabetic Patients, HEPLISAV-B was Well-Tolerated and Induced Higher Rates of Seroprotection than Engerix-B Data Presented at 2018 American Diabetes Association Annual Meeting BERKELEY, [...]
Sanofi: Disclosure of trading in own shares
25/06/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
25/06/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
25/06/2018
Announcement no. 41/2018 Reykjavik, 25 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
EUROBIO SCIENTIFIC VA COMMERCIALISER LA GAMME TRIAGE® DE QUIDEL
25/06/2018
EUROBIO SCIENTIFIC VA COMMERCIALISER LA GAMME TRIAGE® DE QUIDEL Tests rapides pour la cardiologie et le dépistage de drogues dans les urines, totalisant un chiffre d'affaires d'environ 2,5 M€ en France Le Groupe [...]
Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes
25/06/2018
RALEIGH, N.C., June 25, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases, [...]
Gefion Group Investments A/S provisionally extends offer period
25/06/2018
Company announcement 25 June 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Scapa Healthcare Closed Fiscal Year with Significant Enhancements of Capabilities and Technologies
25/06/2018
Expanded North American Manufacturing Footprint through an Acquisition and New Manufacturing Site WINDSOR, Conn., June 25, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin [...]
Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region
25/06/2018
Milestone Reflects Accelerating Adoption of Invisalign Treatment Among Adults and Teens in Europe SAN JOSE, Calif. and AMSTERDAM, The Netherlands, June 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), [...]

Pages